Genetic Signatures Limited (GSS.AX)

0.7000 0.0000 (0.00%) At close: 04:10PM AEST

Genetic Signatures Limited

Heart Research Institute
7 Eliza Street
Newtown, NSW 2042
Australia
61 2 9870 7580
https://www.geneticsignatures.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. John R. Melki BSc, Ph.D.	MD, CEO & Executive Director	470.64k	N/A	N/A
Mr. Michael Anton Aicher BSc, M.B.A., MBA	Executive Director of US Operations & Executive Director	178.42k	N/A	1960
Mr. Christopher M. Abbott	Founder & Chairman Emeritus	N/A	N/A	N/A
Mr. Karl David Pechmann	CFO, COO & Company Secretary	N/A	N/A	N/A
Dr. Douglas S. Millar BSc, Ph.D.	Chief Scientific Officer	289.09k	N/A	N/A
Ms. Rebecca Abbatantuono	Global Head of People & Culture	N/A	N/A	N/A
Ms. Neralie Coulston B.Sc.	Global Head of Regulatory Affairs	N/A	N/A	N/A
Mr. Jackson Jones B.Sc.	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Corporate governance

Genetic Signatures Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.